COVID-19 pandemic The National Medical Products Administration approves China's first mixed-vaccine trial combining "inactivated" CoronaVac made by Sinovac and DNA-based vaccine made by Inovio. China approves first mixed-vaccine trial as Delta spreads - France 24 © France 24 Sources: France 24
